Cargando…
Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study
Transcripts of human endogenous retrovirus K are expressed in most breast cancers (BCs). Yellow fever vaccine 17D (YFV) expresses a protein with a closely homologous epitope. Cross-reactive immunity could hypothetically inhibit BC growth at least in women aged around 50 years at diagnosis, in whom t...
Autores principales: | Mastrangelo, Giuseppe, Pavanello, Sofia, Fadda, Emanuela, Buja, Alessandra, Fedeli, Ugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012044/ https://www.ncbi.nlm.nih.gov/pubmed/27870643 http://dx.doi.org/10.1097/CEJ.0000000000000333 |
Ejemplares similares
-
Work related injuries: estimating the incidence among illegally employed immigrants
por: Mastrangelo, Giuseppe, et al.
Publicado: (2010) -
Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final Results
por: Andersson, Michael, et al.
Publicado: (2017) -
Patterns of Recurrence Among Higher-Risk Patients Receiving Daily External Beam Accelerated Partial-Breast Irradiation to 40 Gy in 10 Fractions
por: Fitzgerald, Kelly, et al.
Publicado: (2019) -
Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer
por: Lander, Eric M, et al.
Publicado: (2022) -
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil
por: Shafaee, Maryam Nemati, et al.
Publicado: (2022)